Chartered accountant with over 30 years' experience in finance and M&A in the pharmaceutical and other sectors.

Previously EVP and CFO at Jamp Pharma for 8 years.

Experienced leader with expertise in pharmaceutical manufacturing and marketing.

Founder, President and CEO of Fera Pharmaceuticals, an American pharmaceutical company specializing in ophthalmic products.

Previously CEO and President of Sandoz US, one of the world's largest and most successful generic pharmaceutical companies.

Member of the Canadian Chartered Professional Accountants (CPA) and of the Institute of Corporate Directors, he holds a Bachelor's degree in Business, with a specialty in Accounting.

Actually the Interim Chief Financial Officer of EXFO Inc. since October 2023 and President of the Board of Director of the Foundation of the University du Quebec at Trois-Rivières where he is a board member since 2013.

Previously, he has been VP and CFO of various publicly traded companies and took part in major financing and acquisition transactions.

Mr. Laflamme is a member of the Quebec CPA Order and holds a bachelor's degree in business administration.

Currently entrepreneur-in-residence for the Medtech Ventures Fund of Sectoral Asset Management Inc.

He was president, CEO, and director of OpSens Inc. (TSX:OPS) from 2013 to 2024. From 2005 to 2012, he was chief financial officer and corporate secretary of OpSens and serves on the board of directors of various companies.